Period of time： 2014年5期
Publisher： Informa Healthcare
Founded in： 2006
Total resources： 77
ISSN： 1746-0441
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Discovery,volume 5,issue 5
Menu
Fragment-based QSAR strategies in drug design
By Salum Lívia B,Andricopulo Adriano D in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 5 , Vol. 5, Iss. 5, 2010-05 , pp.
Access to resources
Recommend
The use of web ontology languages and other semantic web tools in drug discovery
By Chen Huajun,Xie Guotong in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 5 , Vol. 5, Iss. 5, 2010-05 , pp.Systems biology visualization tools for drug target discovery
By Huan Tianxiao,Wu Xiaogang,Chen Jake Y in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 5 , Vol. 5, Iss. 5, 2010-05 , pp.Pharmacophore models for GABAA modulators: implications in CNS drug discovery
By Ghoshal Nanda,Vijayan R Suyambu Kesava in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 5 , Vol. 5, Iss. 5, 2010-05 , pp.Heterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening
By del Burgo Laura Saenz,Milligan Graeme in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 5 , Vol. 5, Iss. 5, 2010-05 , pp.Advances in LC platforms for drug discovery
By Nicoli Raul,Martel Sophie,Rudaz Serge,Wolfender Jean-Luc,Veuthey Jean-Luc,Carrupt Pierre-Alain,Guillarme Davy in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 5 , Vol. 5, Iss. 5, 2010-05 , pp.By Honma Masashi,Kozawa Masanari,Suzuki Hiroshi in (2010)
Expert Opinion on Drug Discovery,volume 5,issue 5 , Vol. 5, Iss. 5, 2010-05 , pp.